• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算希腊与房颤相关的卒中的经济负担。

Estimation of the economic burden of atrial fibrillation-related stroke in Greece.

机构信息

Hellenic Stroke Organization, Athens, Greece.

Pfizer Hellas, Athens, Greece.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2022 Apr;22(3):429-435. doi: 10.1080/14737167.2021.1979961. Epub 2021 Sep 26.

DOI:10.1080/14737167.2021.1979961
PMID:34569402
Abstract

BACKGROUND

Stroke is aleading cause of death and disability, with atrial fibrillation (AF) being among key risk factors and AF-related stroke inflicting significant burden on healthcare systems and society. The present study was undertaken for estimating the total annual socioeconomic burden of AF-related stroke in Greece and identifying the key cost contributors.

RESEARCH DESIGN AND METHODS

A cost-of-illness model was developed for estimating the total annual economic burden of AF-related stroke in Greece, from asocietal perspective (year 2018). Atargeted literature review and an advisory board consisting of key experts in the management of AF and AF-related stroke were performed for collecting local resource use and epidemiological data.

RESULTS

The total annual socioeconomic burden of AF-related stroke was estimated at €175million, in 2018. Direct and indirect costs accounted for 59% and 41%, respectively. Main contributors were informal care (21.1%), patients' productivity losses (19.7%) and hospitalizations (15.0%), accounting for more than half of the total costs of AF-related stroke events. A F-related stroke imposes asignificant socioeconomic burden in Greece. Despite results relying on estimations, it seems that ensuring efficient reallocation of resources in appropriate prevention and early intervention strategies could decrease AF-related stroke's burden but also enhance healthcare systems' efficiency.

ABBREVIATIONS

AF=atrial fibrillation.

摘要

背景

中风是导致死亡和残疾的主要原因,其中心房颤动(AF)是关键的风险因素之一,AF 相关的中风给医疗保健系统和社会带来了巨大的负担。本研究旨在估计希腊 AF 相关中风的总年度社会经济负担,并确定关键的成本贡献者。

研究设计和方法

从社会角度(2018 年)开发了一个疾病成本模型,以估计希腊 AF 相关中风的总年度经济负担。进行了针对性的文献回顾和由 AF 和 AF 相关中风管理方面的主要专家组成的顾问委员会,以收集当地的资源利用和流行病学数据。

结果

2018 年,AF 相关中风的总年度社会经济负担估计为 1.75 亿欧元。直接成本和间接成本分别占 59%和 41%。主要贡献者是非正式护理(21.1%)、患者生产力损失(19.7%)和住院治疗(15.0%),占 AF 相关中风事件总费用的一半以上。AF 相关中风在希腊造成了巨大的社会经济负担。尽管结果依赖于估计,但似乎通过有效重新分配资源,制定适当的预防和早期干预策略,可能会降低 AF 相关中风的负担,同时提高医疗保健系统的效率。

缩写词

AF=心房颤动。

相似文献

1
Estimation of the economic burden of atrial fibrillation-related stroke in Greece.估算希腊与房颤相关的卒中的经济负担。
Expert Rev Pharmacoecon Outcomes Res. 2022 Apr;22(3):429-435. doi: 10.1080/14737167.2021.1979961. Epub 2021 Sep 26.
2
Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece.在希腊,使用醋硝香豆素治疗的心房颤动患者中需要住院治疗的出血事件的发生率和成本。
Hellenic J Cardiol. 2021 May-Jun;62(3):234-240. doi: 10.1016/j.hjc.2020.06.013. Epub 2020 Jul 17.
3
Epidemiology and comprehensive economic impact of atrial fibrillation and associated stroke in Slovakia.斯洛伐克的房颤和相关卒中的流行病学及综合经济影响。
BMC Health Serv Res. 2024 May 17;24(1):637. doi: 10.1186/s12913-024-11100-1.
4
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.阿哌沙班与华法林或阿司匹林用于心房颤动患者预防卒中的成本效益:希腊视角
Am J Cardiovasc Drugs. 2017 Apr;17(2):123-133. doi: 10.1007/s40256-016-0204-1.
5
Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China.比较有无心房颤动的缺血性中风患者的经济负担:一项在中国北京进行的回顾性研究。
Curr Med Res Opin. 2017 Oct;33(10):1789-1794. doi: 10.1080/03007995.2017.1348345. Epub 2017 Aug 9.
6
Economic burden of thromboembolic and hemorrhagic complications in non-valvular atrial fibrillation in Algeria (the ELRAGFA study).阿尔及利亚非瓣膜性心房颤动血栓栓塞和出血并发症的经济负担(ELRAGFA研究)
J Med Econ. 2018 Dec;21(12):1213-1220. doi: 10.1080/13696998.2018.1527341. Epub 2018 Oct 11.
7
The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.缺血性卒中对房颤相关医疗费用的影响:系统评价。
Europace. 2017 Jun 1;19(6):937-947. doi: 10.1093/europace/euw093.
8
Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier: A 15-Year Nationwide Study.心房颤动作为缺血性卒中临床和经济负担的修饰因素:一项为期15年的全国性研究。
Value Health. 2017 Sep;20(8):1083-1091. doi: 10.1016/j.jval.2017.04.018. Epub 2017 Jun 21.
9
[Atrial fibrillation--epidemiologic, economic and individual burden of disease].[心房颤动——疾病的流行病学、经济负担及个体负担]
Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S21-5. doi: 10.1055/s-0030-1249204. Epub 2010 Mar 10.
10
Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.法国住院房颤患者的中风及其他心血管并发症负担
Europace. 2016 Apr;18(4):501-7. doi: 10.1093/europace/euv248. Epub 2015 Dec 30.

引用本文的文献

1
The Cost and the Value of Stroke Care in Greece: Results from the SUN4P Study.希腊中风护理的成本与价值:SUN4P研究结果
Healthcare (Basel). 2023 Sep 14;11(18):2545. doi: 10.3390/healthcare11182545.
2
Signal Quality Analysis for Long-Term ECG Monitoring Using a Health Patch in Cardiac Patients.使用心脏健康贴片对心脏病人进行长期心电图监测的信号质量分析。
Sensors (Basel). 2023 Feb 14;23(4):2130. doi: 10.3390/s23042130.